Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Quality of life and tamoxifen in a breast cancer prevention trial: a summary of findings from the NSABP P-1 study. National Surgical Adjuvant Breast and Bowel Project.

Day R; National Surgical Adjuvant Breast and Bowel Projet P-1 study (NSABP-1)..

Ann N Y Acad Sci. 2001 Dec;949:143-50.

PMID:
11795346
2.

National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.

Vogel VG, Costantino JP, Wickerham DL, Cronin WM.

Clin Cancer Res. 2003 Jan;9(1 Pt 2):495S-501S. Review.

3.
4.

Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.

Ganz PA, Land SR.

Menopause. 2008 Jul-Aug;15(4 Suppl):797-803. doi: 10.1097/gme.0b013e31817be9af. Review.

PMID:
18596601
5.

Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial.

Ganz PA, Day R, Ware JE Jr, Redmond C, Fisher B.

J Natl Cancer Inst. 1995 Sep 20;87(18):1372-82.

PMID:
7658498
6.

Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy.

Veronesi U, Maisonneuve P, Rotmensz N, Bonanni B, Boyle P, Viale G, Costa A, Sacchini V, Travaglini R, D'Aiuto G, Oliviero P, Lovison F, Gucciardo G, del Turco MR, Muraca MG, Pizzichetta MA, Conforti S, Decensi A; Italian Tamoxifen Study Group..

J Natl Cancer Inst. 2007 May 2;99(9):727-37.

PMID:
17470740
7.

Endocrine prevention of breast cancer using selective oestrogen receptor modulators (SORMs).

Lo SS, Vogel VG.

Best Pract Res Clin Endocrinol Metab. 2004 Mar;18(1):97-111. Review.

PMID:
14687600
8.

Breast cancer prevention with selective estrogen receptor modulators: a perspective.

Pritchard KI.

Ann N Y Acad Sci. 2001 Dec;949:89-98. Review.

PMID:
11795385
9.

Chemoprevention for high-risk women: tamoxifen and beyond.

Fabian CJ, Kimler BF.

Breast J. 2001 Sep-Oct;7(5):311-20. Review.

PMID:
11906441
10.
11.
12.
13.

The Royal Marsden Hospital (RMH) trial: key points and remaining questions.

Powles TJ.

Ann N Y Acad Sci. 2001 Dec;949:109-12.

PMID:
11795342
14.

Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.

Abramson N, Costantino JP, Garber JE, Berliner N, Wickerham DL, Wolmark N.

J Natl Cancer Inst. 2006 Jul 5;98(13):904-10.

PMID:
16818854
15.

Breast cancer prevention: a summary of the chemoprevention trial with tamoxifen.

Gould K, Gates ML, Miaskowski C.

Oncol Nurs Forum. 1994 Jun;21(5):835-40. Review. Erratum in: Oncol Nurs Forum 1995 May;22(4):615.

PMID:
7937245
16.

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N.

J Natl Cancer Inst. 2005 Nov 16;97(22):1652-62.

PMID:
16288118
17.

Prevention of hormone-related cancers: breast cancer.

Dunn BK, Wickerham DL, Ford LG.

J Clin Oncol. 2005 Jan 10;23(2):357-67. Review.

PMID:
15637398
18.

Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.

Vogel VG.

Clin Cancer Res. 2001 Dec;7(12 Suppl):4413s-4418s; discussion 4411s-4412s. Review.

PMID:
11916233
19.

National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention Trial.

Giles K, Flynn PJ, Dalton R, Zera R.

Minn Med. 1993 Dec;76(12):25-7.

PMID:
8127293
20.

Re: Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

Cuzick J, Forbes JF, Howell A.

J Natl Cancer Inst. 2006 May 3;98(9):643; author reply 643-4. No abstract available.

PMID:
16670391

Supplemental Content

Support Center